SBX.DE
Price:
$1.68
Market Cap:
$9.49M
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-07
Stock Exchange
XETRA
Ticker
SBX.DE
According to SynBiotic SE’s latest financial reports and current stock price. The company's current Current Ratio is 0.81. This represents a change of -67.48% compared to the average of 2.50 of the last 4 quarters.
The mean historical Current Ratio of SynBiotic SE over the last ten years is 16.64. The current 0.81 Current Ratio has changed 389.57% with respect to the historical average. Over the past ten years (40 quarters), SBX.DE's Current Ratio was at its highest in in the June 2021 quarter at 24.42. The Current Ratio was at its lowest in in the March 2024 quarter at 0.
Average
16.64
Median
1.12
Minimum
0
Maximum
95.30
Discovering the peaks and valleys of SynBiotic SE Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 95.30
Minimum Annual Increase = -99.12%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2023 | 0.81 | -41.90% |
| 2022 | 1.40 | -4.27% |
| 2021 | 1.46 | 75.31% |
| 2020 | 0.84 | -99.12% |
| 2019 | 95.30 | Infinity% |
The current Current Ratio of SynBiotic SE (SBX.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.23
5-year avg
19.96
10-year avg
16.64
SynBiotic SE’s Current Ratio is greater than Maternus-Kliniken AG (0.13), less than aap Implantate AG (1.96), less than NanoRepro AG (49.94), less than Geratherm Medical AG (20.26), less than Oakridge International Limited (2.21), less than AS Latvijas Juras medicinas centrs (0.83), less than elexxion AG (1.79),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.13 | $22.23M | |
| 1.96 | $19.05M | |
| 49.94 | $19.49M | |
| 20.26 | $16.99M | |
| 2.21 | $809.94K | |
| 0.83 | $6.72M | |
| 1.79 | $1.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SynBiotic SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SynBiotic SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is SynBiotic SE's Current Ratio?
How is the Current Ratio calculated for SynBiotic SE (SBX.DE)?
What is the highest Current Ratio for SynBiotic SE (SBX.DE)?
What is the 3-year average Current Ratio for SynBiotic SE (SBX.DE)?
What is the 5-year average Current Ratio for SynBiotic SE (SBX.DE)?
How does the current Current Ratio for SynBiotic SE (SBX.DE) compare to its historical average?